IT1270122B - 6-benzil-4-ossopirimidine sostituite, processo per la loro preparazione e composizioni farmaceutiche che le contengono - Google Patents

6-benzil-4-ossopirimidine sostituite, processo per la loro preparazione e composizioni farmaceutiche che le contengono

Info

Publication number
IT1270122B
IT1270122B ITMI942023A ITMI942023A IT1270122B IT 1270122 B IT1270122 B IT 1270122B IT MI942023 A ITMI942023 A IT MI942023A IT MI942023 A ITMI942023 A IT MI942023A IT 1270122 B IT1270122 B IT 1270122B
Authority
IT
Italy
Prior art keywords
preparation
benzyl
pharmaceutical compositions
oxypyrimidin
replaced
Prior art date
Application number
ITMI942023A
Other languages
English (en)
Inventor
Marino Artico
Silvio Massa
Antonello Mai
Colla Paolo La
Maria Elena Marongiu
Enzo Tramontano
Original Assignee
Ist Superiore Sanita
Univ Cagliari
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ist Superiore Sanita, Univ Cagliari filed Critical Ist Superiore Sanita
Priority to ITMI942023A priority Critical patent/IT1270122B/it
Publication of ITMI942023A0 publication Critical patent/ITMI942023A0/it
Priority to AU38036/95A priority patent/AU3803695A/en
Priority to PCT/EP1995/003912 priority patent/WO1996010565A1/en
Publication of ITMI942023A1 publication Critical patent/ITMI942023A1/it
Application granted granted Critical
Publication of IT1270122B publication Critical patent/IT1270122B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Sono descritte 6-benzil-4-ossopirimidine sostituite di formula (I) (FORMULA I) in cui:X è scelto nel gruppo costituito da O, S;R è scelto nel gruppo costituito da C1-4 alchile, C5-6 cicloalchile;R', R" e Z, uguali o diversi fra loro indicano H, C1-4 alchile considerando che quando X = O R ed R' non possono essere entrambi uguali a H;loro sali farmaceuticamente accettabili e loro derivati solubili;un loro processo di preparazione ed il loro uso per la preparazione di composizioni farmaceutiche utili per il trattamento di infezioni virali.
ITMI942023A 1994-10-04 1994-10-04 6-benzil-4-ossopirimidine sostituite, processo per la loro preparazione e composizioni farmaceutiche che le contengono IT1270122B (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITMI942023A IT1270122B (it) 1994-10-04 1994-10-04 6-benzil-4-ossopirimidine sostituite, processo per la loro preparazione e composizioni farmaceutiche che le contengono
AU38036/95A AU3803695A (en) 1994-10-04 1995-10-04 Substituted 6-benzyl-4-oxopyrimidines, process for their preparation and pharmaceutical compositions containing them
PCT/EP1995/003912 WO1996010565A1 (en) 1994-10-04 1995-10-04 Substituted 6-benzyl-4-oxopyrimidines, process for their preparation and pharmaceutical compositions containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI942023A IT1270122B (it) 1994-10-04 1994-10-04 6-benzil-4-ossopirimidine sostituite, processo per la loro preparazione e composizioni farmaceutiche che le contengono

Publications (3)

Publication Number Publication Date
ITMI942023A0 ITMI942023A0 (it) 1994-10-04
ITMI942023A1 ITMI942023A1 (it) 1996-04-04
IT1270122B true IT1270122B (it) 1997-04-28

Family

ID=11369647

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI942023A IT1270122B (it) 1994-10-04 1994-10-04 6-benzil-4-ossopirimidine sostituite, processo per la loro preparazione e composizioni farmaceutiche che le contengono

Country Status (3)

Country Link
AU (1) AU3803695A (it)
IT (1) IT1270122B (it)
WO (1) WO1996010565A1 (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6111000A (en) * 1999-07-22 2001-02-13 Vertex Pharmaceuticals Incorporated Inhibitors of viral helcase
CN100439343C (zh) * 2006-08-04 2008-12-03 复旦大学 2-烷基硫-5-烷基-6-(1-氰基芳甲基)取代尿嘧啶类化合物及其制备方法和用途
CN100519540C (zh) * 2007-01-09 2009-07-29 云南大学 S-dabo类化合物、其合成方法和用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4612376A (en) * 1983-03-25 1986-09-16 Fujisawa Pharmaceutical Co., Ltd. Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent
GB9012592D0 (en) * 1990-06-06 1990-07-25 Smithkline Beecham Intercredit Compounds

Also Published As

Publication number Publication date
WO1996010565A1 (en) 1996-04-11
ITMI942023A0 (it) 1994-10-04
ITMI942023A1 (it) 1996-04-04
AU3803695A (en) 1996-04-26

Similar Documents

Publication Publication Date Title
HUT61989A (en) Process for producing 2-deoxy-2,3-didehydro-n-acetylneuraminic acid derivatives and analogs, as well as pharmaceutical compositions comprising same as active ingredient
MD1233B1 (en) Erythromycin derivatives, process for their preparation and pharmaceutical composition on base thereof
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
HUT67398A (en) 1h-imidazo(4,5-c)quinolin-4-amin derivatives, pharmaceutical compositions containing them
BG103945A (bg) Производни на 4"-заместен-9-деоксо-9а-аза-9а- хомоеритромицин а
CA2081068A1 (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of .alpha.-d-neuraminic acid
ATE36699T1 (de) Chinonderivate, verfahren zu ihrer herstellung, ihre verwendung und pharmazeutische zusammensetzung.
FI954898A0 (fi) Vesiliukoiset kamptotesiinijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö kasvaintenvastaisina aineina
ES2160949T3 (es) Derivados de fenilen-sulfonamida sustituidos en meta.
TR199902995T2 (xx) 9-Oksim eritromisin t�revleri
IL114894A (en) Pyrrolidine derivatives as endothelin antagonists, pharmaceutical compositions containing them, and their use in the preparation of medicaments
ATE22889T1 (de) 8-chlor-1,5-benzothiazepinderivate, verfahren zur herstellung und pharmazeutische zusammensetzungen.
CA2040982A1 (en) N-(3-fluoro-2-phosphonylmethoxypropyl) derivatives of purine and pyrimidine heterocyclic bases, their preparation and use
HUT67661A (en) New pyrazine derivatives, their preparation and pharmaceutical compositions containing them
AU656466B2 (en) New benzimidazole compounds, a process for their preparation and pharmaceutical compositions containing them
CA2286511A1 (en) Novel macrolide derivatives
NO933611L (no) Anti-tumor- og anti-psoriatiske midler
ATE259369T1 (de) Neue geranylgeranylderivate, verfahren zu deren herstellung und entsprechende pharmazeutische zusammensetzungen
CA2127472A1 (en) New adenosine derivatives, preparation methods and pharmaceutical compositions containing them
UA48958C2 (uk) 9-o-оксимові похідні еритроміцину а та фармацевтична композиція на їх основі
AU5727899A (en) Diaminocyclobutene-3,4-dione derivatives, their preparation and use
MX9806229A (es) Derivados de benzo(c)quinolicina, su preparacion y uso como inhibidores de la 5alfa-reductasas.
MY110004A (en) Biologically active ureido derivatives useful as antimetastatic agents.
AU614204B2 (en) 16-hydroxymethyl amphotericin b derivatives
ATE40127T1 (de) 1,5-benzothiazepinderivate, verfahren zu ihrer herstellung und arzneimittel.

Legal Events

Date Code Title Description
0001 Granted